SE8403268L - 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa - Google Patents

1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa

Info

Publication number
SE8403268L
SE8403268L SE8403268A SE8403268A SE8403268L SE 8403268 L SE8403268 L SE 8403268L SE 8403268 A SE8403268 A SE 8403268A SE 8403268 A SE8403268 A SE 8403268A SE 8403268 L SE8403268 L SE 8403268L
Authority
SE
Sweden
Prior art keywords
atoms
carbon
alkyl
pharmaceutical preparations
preparations containing
Prior art date
Application number
SE8403268A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403268D0 (sv
Inventor
A Vogel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8403268D0 publication Critical patent/SE8403268D0/xx
Publication of SE8403268L publication Critical patent/SE8403268L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8403268A 1983-06-21 1984-06-19 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa SE8403268L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH339483 1983-06-21

Publications (2)

Publication Number Publication Date
SE8403268D0 SE8403268D0 (sv) 1984-06-19
SE8403268L true SE8403268L (sv) 1984-12-22

Family

ID=4255028

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403268A SE8403268L (sv) 1983-06-21 1984-06-19 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa

Country Status (15)

Country Link
JP (1) JPS6013789A (fr)
AU (1) AU2956484A (fr)
BE (1) BE899937A (fr)
CH (1) CH663616A5 (fr)
DE (1) DE3421992A1 (fr)
DK (1) DK299784A (fr)
FR (1) FR2549058B1 (fr)
GB (1) GB2142021B (fr)
IL (1) IL72152A0 (fr)
IT (1) IT1199143B (fr)
LU (1) LU85423A1 (fr)
NL (1) NL8401932A (fr)
SE (1) SE8403268L (fr)
WO (1) WO1985000169A1 (fr)
ZA (1) ZA844725B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
NL8503262A (nl) * 1984-12-10 1986-07-01 Sandoz Ag 1,4-dihydropyridinederivaten, werkwijze voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.
EP0191724A3 (fr) * 1985-01-15 1986-12-03 Sandoz Ag 1,4-Dihydropyridines, leur procédé de préparation et les compositions pharmaceutiques les contenant
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
EP0222702A3 (fr) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Dérivés carbonyliques basiques
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
WO1988007531A1 (fr) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes optiquement actifs
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
JPH03500647A (ja) * 1987-10-27 1991-02-14 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規ピロリジン
JPH10205466A (ja) * 1997-01-23 1998-08-04 Mitsubishi Heavy Ind Ltd スクロール型流体機械

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
JPS57175165A (en) * 1981-04-21 1982-10-28 Tokyo Tanabe Co Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic diester derivative and its salt
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0094159B1 (fr) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dérivés de la dihydropyridine, leur préparation et leur application

Also Published As

Publication number Publication date
DK299784A (da) 1984-12-22
SE8403268D0 (sv) 1984-06-19
AU2956484A (en) 1985-01-03
IL72152A0 (en) 1984-10-31
DK299784D0 (da) 1984-06-19
BE899937A (fr) 1984-12-18
WO1985000169A1 (fr) 1985-01-17
ZA844725B (en) 1986-02-26
GB8415523D0 (en) 1984-07-25
GB2142021B (en) 1987-07-15
CH663616A5 (de) 1987-12-31
FR2549058B1 (fr) 1988-02-19
GB2142021A (en) 1985-01-09
NL8401932A (nl) 1985-01-16
FR2549058A1 (fr) 1985-01-18
LU85423A1 (fr) 1985-03-26
DE3421992A1 (de) 1985-01-03
IT1199143B (it) 1988-12-30
JPS6013789A (ja) 1985-01-24
IT8448415A0 (it) 1984-06-19

Similar Documents

Publication Publication Date Title
AR241528A1 (es) Un procedimiento para la preparacion de n-(3- o 4-((alquilamino)alquil)-fenil)alcansulfonamidas y sus sales.
FI823923A0 (fi) Antifibrinolytiskt aktiva foereningar
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
JPS5432460A (en) Cycloalkylidenemethylphenylacetic acid derivative and their preparation
SE8303013L (sv) B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening
SE8403268L (sv) 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa
ES8403877A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
DK67384A (da) N-iminopyridiniumbetainderivater
HU896775D0 (en) Fungicid compositions comprising sulfurous oximethers as active ingredient and process for preparation thereof
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
ES544955A0 (es) Procedimiento para preparar derivados monobasicos de disobu-tamida
FR2444685A1 (fr) Nouveaux hemiesters alcalins et diesters aliphatiques des acides bis(hydroxy-4 phenyl) alkylphosphoniques
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
JPS527953A (en) Preparation of novel methano-anthracene derivatives
JPS5416466A (en) Novel 3-hydroxypyrrolldine-3-carboxylic derivative
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.
ES2007666A6 (es) Procedimiento para preparar derivados de isoquinolina y composiciones farmaceuticas correspondientes.
SE7905025L (sv) Tereftalsyramonoamidderivat, forfarande for framstellning derav och antiallergiskt medel
JPS6426559A (en) Novel phthalide derivative
JPS5210219A (en) Preparation of beta-sulfonylacrylic beta-sulfonylacrylic their esters and acids their esters and amides
JPS5373508A (en) Hexanol derivative and its preparation
JPS5414987A (en) Novel s-triazine compounds and its preparation
JPS5277066A (en) Preparation of novel pyridone derivative
JPS52125171A (en) Preparation of pyridine derivatives

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8403268-9

Effective date: 19890101